Current and Emerging Therapeutic Approaches for Multiple Myeloma (MM) — Thomas Martin, MD Research To Practice 48:04 3 months ago 117 Далее Скачать
Current use of CAR T-cell therapies in clinical practice Multiple Myeloma Hub 22:17 4 months ago 414 Далее Скачать
Treating multiple myeloma in the UK VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 993 Далее Скачать
How do I treat patients who have relapsed after quadruplet regimen in the first-line in MM? Multiple Myeloma Hub 8:18 1 month ago 265 Далее Скачать
How to Better Diagnose Patients With High-Risk Myeloma | Martin Kaiser, MD | ASH 2022 HealthTree Foundation for Multiple Myeloma 4:21 1 year ago 235 Далее Скачать
What are the latest updates to the NCCN guidelines for the management of MM? Multiple Myeloma Hub 6:19 6 months ago 331 Далее Скачать
Are we ready to use MRD for treatment decisions in patients with MM? Multiple Myeloma Hub 11:32 5 years ago 113 Далее Скачать
Defining and identifying ultra-high-risk multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:11 10 months ago 447 Далее Скачать
Identifying and treating high-risk patients in 2023 Multiple Myeloma Hub 23:23 1 year ago 708 Далее Скачать
Initial results of cilta-cel, a CAR T-cell therapy, in earlier lines of treatment Multiple Myeloma Hub 7:26 3 years ago 157 Далее Скачать
Is treatment discontinuation feasible for patients with myeloma with deep and durable responses? VJHemOnc – Video Journal of Hematology & HemOnc 1:40 2 years ago 82 Далее Скачать
Ultrastratification of multiple myeloma via biomarkers VJHemOnc – Video Journal of Hematology & HemOnc 1:05 5 years ago 65 Далее Скачать
How to decide between bispecific antibodies or CAR T-cell therapies Multiple Myeloma Hub 8:31 4 years ago 283 Далее Скачать
Why do we not see curative CAR T-cell therapy in MM (compared to DLBCL and ALL)? Multiple Myeloma Hub 6:16 4 years ago 277 Далее Скачать
Should 'cure' be the goal for multiple myeloma? Multiple Myeloma Hub 28:10 2 years ago 97 Далее Скачать
What are the key differences between bispecific antibodies and CAR T cells? Multiple Myeloma Hub 3:03 3 years ago 147 Далее Скачать
Roundtable discussion—Multiple Myeloma Hub Satellite Symposium: Should 'cure' be the goal for MM? Multiple Myeloma Hub 27:15 3 years ago 121 Далее Скачать
The microbiome and its effects on the immune system Multiple Myeloma Hub 17:58 4 years ago 122 Далее Скачать
The future of transplantation in NDMM VJHemOnc – Video Journal of Hematology & HemOnc 1:17 2 years ago 36 Далее Скачать
Two major highlights from ASH for patients with relapsed/refractory multiple myeloma Multiple Myeloma Hub 3:45 4 years ago 263 Далее Скачать